000 02048 a2200637 4500
005 20250516222635.0
264 0 _c20150605
008 201506s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.2158
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHall, Amy B
245 0 0 _aPotentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970.
_h[electronic resource]
260 _bOncotarget
_cJul 2014
300 _a5674-85 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aAtaxia Telangiectasia Mutated Proteins
_xantagonists & inhibitors
650 0 4 _aCell Line, Tumor
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDNA
_xdrug effects
650 0 4 _aDNA Damage
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsoxazoles
_xpharmacology
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aPhosphorylation
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aPyrazines
_xpharmacology
650 0 4 _aRandom Allocation
650 0 4 _aSignal Transduction
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aNewsome, Dave
700 1 _aWang, Yuxin
700 1 _aBoucher, Diane M
700 1 _aEustace, Brenda
700 1 _aGu, Yong
700 1 _aHare, Brian
700 1 _aJohnson, Mac A
700 1 _aMilton, Sean
700 1 _aMurphy, Cheryl E
700 1 _aTakemoto, Darin
700 1 _aTolman, Crystal
700 1 _aWood, Mark
700 1 _aCharlton, Peter
700 1 _aCharrier, Jean-Damien
700 1 _aFurey, Brinley
700 1 _aGolec, Julian
700 1 _aReaper, Philip M
700 1 _aPollard, John R
773 0 _tOncotarget
_gvol. 5
_gno. 14
_gp. 5674-85
856 4 0 _uhttps://doi.org/10.18632/oncotarget.2158
_zAvailable from publisher's website
999 _c23995357
_d23995357